Product Comparison

Comparison Options

• Print
• Email
• Export Compare

	No Image
McKesson #	1011143	981867	952614	911398	544446
Description	Printer For Intoxilyzer 400	TDVAX™ Tetanus and Diphtheria Toxoids Adsorbed 2 Lf - 2 Lf / 0.5 mL Injection 0.5 mL	Gardasil® 9 Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free 20 mcg - 60 mcg / 0.5 mL Injection 0.5 mL	Pneumovax® 23 Pneumococcal 23 Vaccine Polyvalent 25 mcg / 0.5 mL Injection 0.5 mL	RotaTeq® Rotavirus Vaccine, Live, Oral Pentavalent Solution 2 mL
Manufacturer #	DS481	13533013101	00006412102	00006483703	00006404741
Brand		TDVAX™	Gardasil® 9	Pneumovax® 23	RotaTeq®
Manufacturer	Jant Pharmacal Corp	Grifols Therapeutics Inc (TDVAX)	Merck	Merck	Merck
Invoice		TDVAX, SDV 0.5ML (10/PK)	GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX)	PNEUMOVAX, SYR 0.5ML (10/CT)	ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Application		Td Vaccine	Human Papillomavirus Vaccine (HPV)	Pneumonia Vaccine	Rotavirus Vaccine
Container Type		Single-Dose Vial	Prefilled Syringe	Prefilled Syringe	Single-Dose Tube
Country of Origin	Unknown	Unknown	United States	United States	United States
Dosage Form		Injection	Injection	Injection	Solution
Generic Drug Code		20835	37568	43859	26500
Generic Drug Name		Tetanus and Diphtheria Toxoids Adsorbed	Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free	Pneumococcal 23 Vaccine Polyvalent	Rotavirus Vaccine, Live, Oral Pentavalent
NDC Number		13533013101	00006412102	00006483703	00006404741
Product Dating		McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements		Requires Refrigeration	Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Strength		2 Lf - 2 Lf / 0.5 mL	20 mcg - 60 mcg / 0.5 mL	25 mcg / 0.5 mL
Type		Intramuscular	Intramuscular	Intramuscular or Subcutaneous	Oral
UNSPSC Code		51201629	51201649	51201615	51201618
User		Indicated for People 7 Years of Age and Older	Indicated for People 9 to 45 Years of Age	Indicated for People 50 Years of Age and Older	Indicated for People 6 to 32 Weeks of Age
Volume		0.5 mL	0.5 mL	0.5 mL	2 mL
Features and Benefits			GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58	PNEUMOVAX 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine PNEUMOVAX 23 is approved for use in persons 50 years of age or older and persons aged >2 years who are at increased risk for pneumococcal disease Box of 10 single-dose, pre-filled Luer-Lok™ syringes with tip caps, color coded with a violet plunger rod and purple stripe on the syringe labels and cartons Store unopened and opened vials at 2° - 8°C (36° - 46°F)	The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals 10 individually pouched single dose tubes Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration